Your browser doesn't support javascript.
Induction of ketosis as a potential therapeutic option to limit hyperglycemia and prevent cytokine storm in COVID-19.
Sukkar, Samir Giuseppe; Bassetti, Matteo.
  • Sukkar SG; Dietetics and Clinical Nutrition Unit, Genoa University. Ospedale Policlinico San Martino di Genova IRCCS per l'Oncologia e la Neurologia, Genova, Italy. Electronic address: Samir.sukkar@hsanmartino.it.
  • Bassetti M; Infectious Disease Clinic, Genoa University, Ospedale Policlinico San Martino di Genova IRCCS per l'Oncologia e la Neurologia, Genova, Italy.
Nutrition ; 79-80: 110967, 2020.
Article in English | MEDLINE | ID: covidwho-704014
ABSTRACT
The severe form of coronavirus disease 19 (COVID-19) is characterized by cytokine storm syndrome (CSS) and disseminated intravascular coagulation (DIC). Diabetes, obesity, and hypertension have, as minor common denominators, chronic low-grade inflammation and high plasma myeloperoxidase levels, which could be linked to pulmonary phagocytic hyperactivation and CSS. The hyperactivation of M1 macrophages with a proinflammatory phenotype, which is linked to aerobic glycolysis, leads to the recruitment of monocytes, neutrophils, and platelets from circulating blood and plays a crucial role in thrombo-inflammation (as recently demonstrated in COVID-19) through the formation of neutrophil extracellular traps and monocyte-platelet aggregates, which could be responsible for DIC. The modulation of glucose availability for activated M1 macrophages by means of a eucaloric ketogenic diet (EKD) could represent a possible metabolic tool for reducing adenosine triphosphate production from aerobic glycolysis in the M1 macrophage phenotype during the exudative phase. This approach could reduce the overproduction of cytokines and, consequently, the accumulation of neutrophils, monocytes, and platelets from the blood. Second, an EKD could be advantageous for the metabolism of anti-inflammatory M2 macrophages because these cells predominantly express oxidative phosphorylation enzymes and are best fed by the oxidation of fatty acids in the mitochondria. An EKD could guarantee the availability of free fatty acids, which are an optimal fuel supply for these cells. Third, an EKD, which could reduce high lactate formation by macrophages due to glycolysis, could favor the production of interferon type I, which are inhibited by excessive lactate production. From a practical point of view, the hypothesis, in addition to being proven in clinical studies, must obviously take into account the contraindications of an EKD, particularly type 1 or 2 diabetes treated with drugs that can cause hypoglycemia, to avoid the risk for side effects of the diet.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Cytokines / Diet, Carbohydrate-Restricted / COVID-19 / Hyperglycemia / Inflammation / Ketosis / Macrophages Type of study: Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Nutrition Journal subject: Nutritional Sciences Year: 2020 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Cytokines / Diet, Carbohydrate-Restricted / COVID-19 / Hyperglycemia / Inflammation / Ketosis / Macrophages Type of study: Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Nutrition Journal subject: Nutritional Sciences Year: 2020 Document Type: Article